CCO Infectious Disease Podcast

433 Episodo

1. Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities

   Publicado: 17/1/2023
2. Emerging Insights on Outpatient Management of Acute COVID-19 and Long COVID in Europe

   Publicado: 13/1/2023
3. Administration of LA ART by Community Nurses in France

   Publicado: 5/1/2023
4. Optimizing PrEP Selection and Persistence for MSM

   Publicado: 5/1/2023
5. PrEP Considerations for Transgender and Nonbinary Individuals

   Publicado: 5/1/2023
6. What Strategies Are Most Promising for Prevention and Treatment of Long COVID in Nonhospitalized Patients?

   Publicado: 4/1/2023
7. Should We Be Concerned About Resistance and Development of New Variants With COVID-19 Antiviral Therapy?

   Publicado: 4/1/2023
8. ART Selection in Treatment-Naive PWH: Weight Gain Considerations

   Publicado: 30/12/2022
9. Should We Be Concerned About Viral Rebound With Antiviral Agents?

   Publicado: 30/12/2022
10. Selecting First-line ART in Treatment-Naive Persons With HIV

    Publicado: 29/12/2022
11. If Treatment Supply Is Limited in Future COVID-19 Viral Peaks, How Do We Ethically Prioritize Patients for Treatment?

    Publicado: 29/12/2022
12. Promoting Meningococcal Vaccine Equity in Adolescent Patients

    Publicado: 29/12/2022
13. Will New COVID-19 Vaccines Affect Risk Stratification?

    Publicado: 27/12/2022
14. The Future of Long-Acting HIV Care: What’s Still Needed

    Publicado: 22/12/2022
15. Improving Access and Acceptance of HIV PrEP for People Who Inject Drugs

    Publicado: 20/12/2022
16. Answering the Questions on Monkeypox in PWH

    Publicado: 19/12/2022
17. Answering the Questions on Considering an ART Switch During Pregnancy

    Publicado: 19/12/2022
18. Expanding Access to Long-Acting ART in Europe

    Publicado: 19/12/2022
19. Whom to Screen for Hepatitis Delta Virus

    Publicado: 15/12/2022
20. Hong Kong Perspective: Should Older Age Influence Hepatitis B Treatment Decisions?

    Publicado: 15/12/2022